Primary central nervous system lymphoma treated with rituximab plus temozolomide in a second line schedule

Santisteban, M; Nieto, Y; Cruz, S de la; Aristu, J; Zubieta, JL; Fernández Hidalgo, O

Santisteban, M; Nieto, Y; Cruz, S de la; Aristu, J; Zubieta, JL; Fernández Hidalgo, O.

Affiliation

Santisteban, M; Clínica Universitaria de Navarra. Pamplona. Spain
Nieto, Y; Clínica Universitaria de Navarra. Pamplona. Spain
Cruz, S de la; Clínica Universitaria de Navarra. Pamplona. Spain
Aristu, J; Clínica Universitaria de Navarra. Pamplona. Spain
Zubieta, JL; Clínica Universitaria de Navarra. Pamplona. Spain
Fernández Hidalgo, O; Clínica Universitaria de Navarra. Pamplona. Spain

Clin. transl. oncol. (Print) ; 9(7): 465-467, jul. 2007.

Article de En | IBECS | ID: ibc-123339

Bibliothèque responsable: ES1.1

Localisation: BNCS

ABSTRACT

ABSTRACT

We report a case of primary CNS lymphoma treated with high-dose methotrexate in the first line. After disease progression the patient received cranial radiotherapy with concomitant temozolomide, followed by rituximab plus temozolomide, with complete remission of the disease maintained for at least two years and without major toxicity (AU)

Sujet(s)

Recherche sur Google

Ajouter à My VHL

Imprimer

XML

Collection: 06-national / ES Base de données: IBECS Sujet principal: Tumeurs du système nerveux central / Dacarbazine / Lymphomes / Anticorps monoclonaux / Antinéoplasiques Limites: Female / Humans Langue: En Journal: Clin. transl. oncol. (Print) Année: 2007 Type de document: Article

Recherche sur Google

Ajouter à My VHL

Imprimer

XML